Increase in luteinizing hormone is linked to reduction in depression in patients with dementia: Secondary analysis of a randomized clinical trial of benzoate

Documenti analoghi

• Sodium benzoate, a D‐amino acid oxidase inhibitor, improved short‐term memory in patients with mild cognitive impairment in a randomized, double‐blind, placebo‐controlled clinical trial
  di: Chieh‐Hsin Lin, et al.
  Pubblicazione: (2025)
• Comparison of multiple non‐invasive neuromodulation strategies for depressive episodes in major depressive disorder and bipolar disorder: A systematic review and network meta‐analysis of randomized controlled trials
  di: Ping Wang, et al.
  Pubblicazione: (2025)
• Normative brain variability, clinical dimension, and molecular‐transcriptomic correlates of bipolar risk in depressed patients
  di: Junneng Shao, et al.
  Pubblicazione: (2026)
• Smartphone cognitive behavioral therapy for prevention of depressive symptoms in patients with recurrent pregnancy loss: an exploratory decentralized, parallel‐group, multicenter, open, individually randomized, fully factorial trial
  di: Sakura Ogasawara, et al.
  Pubblicazione: (2025)
• Efficacy and safety of each class of sleep medication for major depressive disorder with insomnia symptoms: A systematic review and meta‐analysis of double‐blind randomized controlled trials
  di: Taku Maruki, et al.
  Pubblicazione: (2025)